Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Impressive Separation of a Fusion Protein
Friday, August 29, 2014
Separation of protein by high-resolution hydrophobic interaction chromatography method.

Exquisite ‘Made-to-Measure’ Phospho-Specific Polyclonal Antibodies
Thursday, August 21, 2014
AMSBIO’s antibody production service is reliable and produces high quality product.

New Hydrophobic Interaction Column from Thermo Fisher Scientific
Wednesday, August 20, 2014
Laboratories are offered additional selectivity for separating monoclonal antibodies or antibody-drug conjugates.

Seward Introduces Additional Sample Handling Alternatives to Pipette Tips
Friday, August 08, 2014
Simplette® straw range expanded to fit more pipette handset types.

Labfors with LabCIP Now Even More Space-Saving and Effective
Wednesday, August 06, 2014
The self-cleaning, self-sterilising bench-top bioreactor is the world’s first.

CCRM Uses ambr15 for Pluripotent Stem Cell Expansion
Tuesday, August 05, 2014
New protocols increase stem cell expansion outputs and improve differentiation into cardiomyocytes.

New Eppendorf Cell Culture Consumables
Friday, August 01, 2014
Product, performance and packaging: Eppendorf consumables deliver quality in all.

Lophius Biosciences Launches Interactive T CELL TOOLS Product Finder
Thursday, July 17, 2014
New T CELL TOOLS product line with Company’s new e-commerce online order portal.

Stainless Steel Vial Filling System Developed for use in Vaccine Facilities
Thursday, July 17, 2014
Provides enhanced operator safety and effective decontamination capabilities.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 482
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv